Lucid Diagnostics (LUCD) EBT Margin Growth (1y) (2022 - 2026)
Lucid Diagnostics (LUCD) EBT Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 165.00 |
| 10 | Lucid Diagnostics | 176.75 Mn | 143.35 Mn | 55,000.00 | -39,745.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -39,745.00 |
| Mar 31, 2026 | 217,984.00 |
| Dec 31, 2025 | -12,169.00 |
| Sep 30, 2025 | 19,700.00 |
| Jun 30, 2025 | 75,764.00 |
| Mar 31, 2025 | -218,962.00 |
| Dec 31, 2024 | 7,719.00 |
| Sep 30, 2024 | 75,901.00 |
| Jun 30, 2024 | 603,030.00 |
| Mar 31, 2024 | 258,269.00 |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.71 Mn |
| Mar 31, 2023 | 284,924.00 |
| Dec 31, 2022 | -955,990.00 |
| Sep 30, 2022 | -1.54 Mn |